Elisa Peranzoni

The paper identifies monocyte interactions with CD8+ T cells during tumor regression, showing their role in promoting T-cell infiltration and anti-tumor immunity.

This paper develops a peptide-drug conjugate, MACTIDE-V, that reprograms tumor-associated macrophages in breast cancer, reducing metastasis and enhancing anti-tumor immunity.

This study shows that blocking β-adrenergic receptor signaling enhances cancer vaccine efficacy by improving naive CD8+ T-cell priming, without affecting tumor-infiltrating CD8+ T-cell reactivity.